David Marriott, who operates out of Cravath, Swaine & Moore LLP‘s New York office, has acted in precedent-setting trials in recent years, including the first vertical merger challenge to go to the FTC in 40 years. In 2023, Mariott was lead counsel in a case for Amgen Inc, one of the biggest biopharmaceutical companies in the world in relation to its $27.8 billion acquisition of Horizon Therapeutics. Marriott is an experienced trial lawyer with many successes, and has a strong record in areas such as antitrust, employment, and IP.